EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Mylan N.V. - MYL
October 11 2016 - 11:20AM
Business Wire
Rosen Law Firm, a global investor rights law firm, announces
that it has filed a class action lawsuit on behalf of purchasers of
common stock of Mylan Inc., predecessor of Mylan N.V., and/or Mylan
N.V. ordinary shares (NASDAQ: MYL) from February 28, 2013 through
October 7, 2016, both dates inclusive (the “Class Period”).
To join the Mylan class action, go to the website at
http://www.rosenlegal.com/cases-967.html or call Phillip Kim, Esq.
or Kevin Chan, Esq. toll-free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for information on the
class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants
made false and/or misleading statements and/or failed to disclose
that: (1) Mylan N.V. and Mylan Inc. incorrectly classified EpiPen
as a generic under the Medicaid Drug Rebate Program, which was
financially consequential for federal and state governments as it
reduced the amount of quarterly rebates Mylan N.V. and Mylan Inc.
owed for EpiPen; (2) between 2011 through 2015, Mylan N.V. and
Mylan Inc. paid a lower rebate of 13% when it should have been
paying a higher rebate of 23.1% or more; (3) the incorrect
classification appears to have cost the federal government more
than $100 million in the last five years alone; (4) in turn, Mylan
N.V. and Mylan Inc. lacked effective internal controls over
financial reporting; and (5) as a result, Mylan N.V. and Mylan
Inc.’s public statements were materially false and misleading at
all relevant times. The lawsuit claims that investors suffered
damages when these details entered the market.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
December 12, 2016. If you wish to join the litigation, go to
http://www.rosenlegal.com/cases-967.html or to discuss your rights
or interests regarding this class action, please contact Phillip
Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or
via email at pkim@rosenlegal.com or kchan@rosenlegal.com.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161011006281/en/
The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212)
202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Apr 2023 to Apr 2024